WuXi AppTec’s partner, Hutchison MediPharma (HMP), has received approval of fruquintinib capsules (Elunate®) for metastatic colorectal cancer from the National Medical Products Administration of China (“NMPA”) – formerly the China Food and Drug Administration. Fruquintinib is an innovative medicine that has not previously been launched in China or internationally. The approval in China was completed using a priority review and approval process, thereby maximizing the number of pot...